Jingjing Jiang

Jingjing Jiang

Company: Revolution Medicines

Job title: Senior Director, Translational Research


Combination Therapy to Outsmart RASAddicted Cancer – Informing Clinical Strategy with Preclinical Modeling 11:45 am

Identify biomarkers that can help direct the “right combination regimen” to the “right patients” Define upfront combination regimens that can prevent/ delay emergent resistance mechanisms to RevMed RAS(ON) inhibitors Understand if/how we can translate learnings between distinct RAS mutations and cancer histotypesRead more

day: Translation Track - Day 1 am

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.